YOD1 regulates oxidative damage of dopamine neurons in Parkinson's disease by deubiquitinating PKM2
Open Access
- 18 July 2025
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 15 (7) , e70420
Abstract
Background: Parkinson's disease (PD) is a common neurodegenerative movement disorder, mainly characterized by the degeneration and loss of dopaminergic neurons in the substantia nigra. Oxidative stress is considered to be a key contributor to dopaminergic neuronal degeneration, triggering a series of downstream events such as mitochondrial dysfunction, neuroinflammation and misfolded protein aggregation, which ultimately exacerbate the development of PD. Deubiquitinating enzymes (DUBs) regulate oxidative stress, but their roles in PD remain unclear.Methods: GEO database analysis and western blotting were used to analyze the expression of YOD1in PD patients and PD mouse models. Genetic knockout (KO) of YOD1 was performed to assess its effects in PD pathogenesis. The substance of YOD1 was measured via co‐immunoprecipitation (Co‐IP) coupled with LC‐MS/MS analysis. Then the effect of YOD1‐mediated motor deficits and oxidative damage were investigated using open field test, swimming test, pole test, immunofluorescence (IF) and cellular analyses.Results: YOD1 was highly expressed in PD patients and 6‐OHDA‐induced PD model mice and mediated reactive oxygen species (ROS) production. YOD1 KO ameliorated motor impairments and oxidative stress in PD model mice. YOD1 directly bound PKM2 and reduces its ubiquitination level by removing the K63‐linked ubiquitin chain of PKM2, thereby increasing the tetramer level and reducing the dimer level of PKM2. It then inhibited dimerized PKM2 entry into the nucleus and regulated Nrf2‐mediated antioxidant responses, but YOD1 does not change the stability of PKM2 protein.Conclusions: Our study identifies YOD1 as a oxidative‐sensitive regulator of PD progression, operating via the YOD1‐PKM2‐Nrf2 axis. Targeting YOD1 may offer a novel therapeutic strategy for PD.Key points: YOD1 is highly elevated in different PD model mice and patients with PD. YOD1 is a key regulator in oxidative stress and PD pathology. YOD1‐deficient exhibit a protective effect on neuronal oxidative injury. YOD1 targets PKM2-Nrf2 axis in response to oxidative stress.Keywords
Funding Information
- National Natural Science Foundation of China (21961142009, 82360805)
This publication has 47 references indexed in Scilit:
- Ubiquitin at the crossroad of cell death and survivalChinese Journal of Cancer, 2013
- Mitochondrial dysfunction and oxidative stress in Parkinson's diseaseProgress in Neurobiology, 2013
- The Role of Oxidative Stress in Parkinson's DiseaseJournal of Parkinson’s Disease, 2013
- The Nrf2-antioxidant response element pathway: a target for regulating energy metabolismThe Journal of Nutritional Biochemistry, 2012
- Tyrosine hydroxylase and regulation of dopamine synthesisArchives of Biochemistry and Biophysics, 2011
- Oxidative Toxicity in Neurodegenerative Diseases: Role of Mitochondrial Dysfunction and Therapeutic StrategiesJournal of Toxicology, 2011
- Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating EnzymesAnnual Review of Biochemistry, 2009
- Three Types of Tyrosine Hydroxylase-Positive CNS Neurons Distinguished by Dopa Decarboxylase and VMAT2 Co-ExpressionCellular and Molecular Neurobiology, 2006
- Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant α-synucleins related to Parkinson's diseaseNeurochemistry International, 2006
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003